CVE-2023-27167

MEDIUMCVSS 6.5/10EPSS 7.50%

Last modified

CVE-2023-27167 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. Suprema BioStar 2 v2.8.16 was discovered to contain a SQL injection vulnerability via the values parameter at /users/absence?search_month=1.. EPSS estimates a 7.50% chance of exploitation in the next 30 days.

Description

Suprema BioStar 2 v2.8.16 was discovered to contain a SQL injection vulnerability via the values parameter at /users/absence?search_month=1.

Metrics

CVSS 3.1
6.5/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

EPSS Probability
7.50%

93.7th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
SupremaincBiostar 2<= 2.8.16

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-27167?
Suprema BioStar 2 v2.8.16 was discovered to contain a SQL injection vulnerability via the values parameter at /users/absence?search_month=1.
How severe is CVE-2023-27167?
CVE-2023-27167 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 7.50% probability of exploitation in the next 30 days.
How do I fix CVE-2023-27167?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-27167?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST